相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
M. Schmidt et al.
ANNALS OF ONCOLOGY (2012)
Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective
F. Penault-Llorca et al.
ANNALS OF ONCOLOGY (2012)
Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines
Agnieszka Martowicz et al.
BMC CANCER (2012)
EpCAM expression is an indicator of recurrence in basal-like breast cancer
Ayodeji J. Agboola et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer
Coya Tapia et al.
HUMAN PATHOLOGY (2011)
EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis
Gilbert Spizzo et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion
Narendra V. Sankpal et al.
BREAST CANCER RESEARCH (2011)
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
M. Schmidt et al.
ANNALS OF ONCOLOGY (2010)
EpCAM in carcinogenesis: the good, the bad or the ugly
Bernardina T. F. van der Gun et al.
CARCINOGENESIS (2010)
Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion
Narendra V. Sankpal et al.
CANCER RESEARCH (2009)
Dual Expression Lentiviral Vectors for Concurrent RNA Interference and Rescue
Narendra V. Sankpal et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Nuclear signalling by tumour-associated antigen EpCAM
Dorothea Maetzel et al.
NATURE CELL BIOLOGY (2009)
Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer
Marcus Schmidt et al.
CLINICAL CANCER RESEARCH (2008)
DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression
K-Y Tai et al.
ONCOGENE (2007)
Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer
Gilbert Spizzo et al.
GYNECOLOGIC ONCOLOGY (2006)
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
P Went et al.
BRITISH JOURNAL OF CANCER (2006)
Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer
I Songun et al.
BRITISH JOURNAL OF CANCER (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy
WA Osta et al.
CANCER RESEARCH (2004)
High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer
G Spizzo et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation
M Münz et al.
ONCOGENE (2004)
Frequent EpCam protein expression in human carcinomas
PT Went et al.
HUMAN PATHOLOGY (2004)
Prognostic significance of Ep-CAM and Her-2/neu overexpression in invasive breast cancer
G Spizzo et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Tissue microarray (TMA) technology:: miniaturized pathology archives for high-throughput in situ studies
L Bubendorf et al.
JOURNAL OF PATHOLOGY (2001)
Ep-CAM overexpression in breast cancer as a predictor of survival
G Gastl et al.
LANCET (2000)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
